Coherus BioSciences Inc. (CHRS)
NASDAQ: CHRS
· Real-Time Price · USD
1.05
0.03 (2.94%)
At close: Aug 15, 2025, 3:48 PM
Coherus BioSciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 142.77M | 197.5M | 192.21M | 229.59M | 233.38M | 227.12M | 257.24M | 211.07M | 181.93M | 183.36M | 211.04M | 239.06M | 276.14M | 303.63M | 326.55M | 363.6M | 394.65M | 442.68M |
Cost of Revenue | 61.66M | 86.81M | 120.25M | 172.02M | 183.98M | 179.27M | 160.06M | 88.63M | 91.16M | 77.59M | 70.08M | 67.98M | 54.03M | 59.45M | 57.59M | 57.16M | 44.88M | 38.32M |
Gross Profit | 81.11M | 110.69M | 146.71M | 132.32M | 124.15M | 122.6M | 97.19M | 122.44M | 90.77M | 105.78M | 140.96M | 171.08M | 222.11M | 244.18M | 268.96M | 306.44M | 349.77M | 404.36M |
Operating Income | -139.55M | -114.58M | -111.67M | -137.78M | -163.4M | -177.43M | -202.65M | -185.79M | -234.23M | -243.7M | -256.88M | -244.93M | -197.27M | -177.42M | -263.86M | -207.89M | -141.38M | -51.91M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -153.71M | -121.77M | 28.51M | -450K | -29.72M | -59.67M | -238.27M | -217.49M | -264.12M | -271.4M | -291.75M | -278.61M | -230.49M | -210.24M | -287.1M | -230.62M | -163.97M | -73.75M |
Net Income | 179.75M | -130.94M | 28.51M | -450K | -29.34M | -59.29M | -236.94M | -223.54M | -276.75M | -290.17M | -326.63M | -306.11M | -251.78M | -225.4M | -287.1M | -231.67M | -165.21M | -76.28M |
Selling & General & Admin | 128.1M | 137.23M | 160.94M | 168.59M | 182.07M | 192.05M | 191.47M | 196.14M | 192.75M | 198.88M | 198.48M | 194.91M | 190.01M | 179.07M | 169.71M | 157.35M | 149.41M | 143.12M |
Research & Development | 93.57M | 88.03M | 90.64M | 94.71M | 98.68M | 101.18M | 108.37M | 112.09M | 132.25M | 150.59M | 199.36M | 221.1M | 229.38M | 242.53M | 363.11M | 356.97M | 341.74M | 313.14M |
Other Expenses | -1.02M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 443K | 475K | 90K | 120K | -312K | -283K | 108K | 134K | 546K |
Operating Expenses | 220.66M | 225.27M | 251.58M | 263.3M | 280.75M | 293.23M | 299.84M | 308.23M | 325M | 349.48M | 397.84M | 416.01M | 419.38M | 421.61M | 532.82M | 514.33M | 491.15M | 456.26M |
Interest Expense | 15.13M | 18.19M | 27.16M | 32.43M | 37.34M | 41.95M | 40.54M | 39.31M | 36.58M | 33.22M | 32.47M | 28.88M | 27.11M | 26.28M | 22.96M | 22.84M | 22.72M | 22.38M |
Selling & Marketing Expenses | 10.9M | 10.9M | 10.9M | 10.9M | 10.9M | 10.9M | 10.9M | 10.5M | 10.5M | 10.5M | 10.5M | 8.7M | 8.7M | 8.7M | 8.7M | 3.8M | 3.8M | 3.8M |
Cost & Expenses | 282.32M | 312.07M | 329.13M | 392.63M | 422.04M | 429.81M | 459.9M | 396.86M | 416.16M | 427.06M | 467.92M | 484M | 473.41M | 481.06M | 590.41M | 571.49M | 536.03M | 494.59M |
Income Tax Expense | -342.63M | n/a | n/a | n/a | -380K | -380K | -1.33M | 6.05M | 12.63M | 18.77M | 34.87M | 27.5M | 21.3M | 15.16M | n/a | 1.05M | 1.24M | 2.53M |
Shares Outstanding (Basic) | 116.08M | 115.86M | 115.42M | 115.21M | 114.82M | 112.75M | 111.49M | 97.74M | 87.27M | 79.27M | 77.96M | 77.75M | 77.15M | 77.25M | 76.35M | 78.63M | 75.56M | 72.83M |
Shares Outstanding (Diluted) | 116.08M | 115.86M | 115.42M | 115.21M | 114.82M | 125.53M | 111.49M | 97.74M | 87.27M | 79.27M | 77.96M | 77.75M | 77.55M | 77.25M | 76.83M | 79.01M | 75.56M | 72.83M |
EPS (Basic) | -1.38 | -1.13 | 0.27 | -0.00 | -0.32 | -0.7 | -2.55 | -2.69 | -3.47 | -3.71 | -4.21 | -3.96 | -3.26 | -2.93 | -3.86 | -3.13 | -2.25 | -1.02 |
EPS (Diluted) | -1.38 | -1.13 | 0.18 | -0.09 | -0.41 | -0.79 | -2.55 | -2.69 | -3.47 | -3.71 | -4.21 | -3.96 | -3.26 | -2.93 | -3.86 | -3.14 | -2.32 | -1.22 |
EBITDA | -137.84M | -98.76M | 60.94M | 37.29M | 13.01M | -12.63M | -193.2M | -173.66M | -223.76M | -234.38M | -255.66M | -245.74M | -198.83M | -179.44M | -259.01M | -203.24M | -137.53M | -48.19M |
EBIT | -138.57M | -103.57M | 55.66M | 31.98M | 7.62M | -17.72M | -197.73M | -178.18M | -227.54M | -238.18M | -259.28M | -249.73M | -203.37M | -183.96M | -264.14M | -207.78M | -141.25M | -51.36M |
Depreciation & Amortization | 4.64M | 4.82M | 5.28M | 5.31M | 5.39M | 5.09M | 4.53M | 4.52M | 3.78M | 3.8M | 3.62M | 3.99M | 4.54M | 5.08M | 5.69M | 5.11M | 4.35M | 3.66M |